Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies
- Author
- MURRAY, R. J1 ; KURILLA, M. G; BROOKS, J. M1 ; THOMAS, W. A1 ; ROWE, M1 ; KIEFF, E; RICKINSON, A. B1
[1] Univ. Birmingham, cancer res. campaign laboratories, dep. cancer studies, Birmingham B15 2TJ, United Kingdom - Source
The Journal of experimental medicine. 1992, Vol 176, Num 1, pp 157-168 ; ref : 53 ref
- Publisher
- Rockefeller University Press, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antigène Cellule infectée Cytotoxicité Homme Immunogénicité Lymphocyte T Reconnaissance Virus Epstein Barr Virus recombinant Virus vaccine Restriction histocompatibilité Chordopoxvirinae Gammaherpesvirinae Herpesviridae Orthopoxvirus Poxviridae Virus
- Keyword (en)
- Antigen Infected cell Cytotoxicity Human Immunogenicity T-Lymphocyte Recognition Epstein Barr virus Recombinant virus Vaccinia virus Chordopoxvirinae Gammaherpesvirinae Herpesviridae Orthopoxvirus Poxviridae Virus
- Keyword (es)
- Antígeno Célula infectada Citotoxicidad Hombre Inmunogenicidad Linfocito T Reconocimiento Epstein Barr virus Virus recombinante Vaccinia virus Chordopoxvirinae Gammaherpesvirinae Herpesviridae Orthopoxvirus Poxviridae Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A06 Fundamental immunology / 002A06B Molecular immunology / 002A06B02 Antigens / 002A06B02A Antigenic determinants, haptens, artificial antigens
- Discipline
- Fundamental immunology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 4336865
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1084/jem.176.1.157 
https://dx.doi.org/10.1084/jem.176.1.157
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1084\/jem.176.1.157\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:9:\"\u0000*\u0000jtitle\";s:36:\"The Journal of experimental medicine\";s:9:\"\u0000*\u0000stitle\";s:11:\"J. exp. med\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:3:\"176\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"157\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1007\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MURRAY\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"KURILLA, M. G\";i:1;s:12:\"BROOKS, J. M\";i:2;s:12:\"THOMAS, W. A\";i:3;s:7:\"ROWE, M\";i:4;s:8:\"KIEFF, E\";i:5;s:15:\"RICKINSON, A. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JEMEAV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:28:\"Rockefeller University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1084\/jem.176.1.157\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:9:\"\u0000*\u0000jtitle\";s:36:\"The Journal of experimental medicine\";s:9:\"\u0000*\u0000stitle\";s:11:\"J. exp. med\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:3:\"176\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"157\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1007\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MURRAY\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"KURILLA, M. G\";i:1;s:12:\"BROOKS, J. M\";i:2;s:12:\"THOMAS, W. A\";i:3;s:7:\"ROWE, M\";i:4;s:8:\"KIEFF, E\";i:5;s:15:\"RICKINSON, A. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JEMEAV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:28:\"Rockefeller University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1084\/jem.176.1.157\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1084\/jem.176.1.157\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:9:\"\u0000*\u0000jtitle\";s:36:\"The Journal of experimental medicine\";s:9:\"\u0000*\u0000stitle\";s:11:\"J. exp. med\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:3:\"176\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"157\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1007\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MURRAY\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"KURILLA, M. G\";i:1;s:12:\"BROOKS, J. M\";i:2;s:12:\"THOMAS, W. A\";i:3;s:7:\"ROWE, M\";i:4;s:8:\"KIEFF, E\";i:5;s:15:\"RICKINSON, A. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JEMEAV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:28:\"Rockefeller University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1084\/jem.176.1.157\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:9:\"\u0000*\u0000jtitle\";s:36:\"The Journal of experimental medicine\";s:9:\"\u0000*\u0000stitle\";s:11:\"J. exp. med\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:3:\"176\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"157\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1007\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MURRAY\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"KURILLA, M. G\";i:1;s:12:\"BROOKS, J. M\";i:2;s:12:\"THOMAS, W. A\";i:3;s:7:\"ROWE, M\";i:4;s:8:\"KIEFF, E\";i:5;s:15:\"RICKINSON, A. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JEMEAV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:28:\"Rockefeller University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1084\/jem.176.1.157\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:9:\"\u0000*\u0000jtitle\";s:36:\"The Journal of experimental medicine\";s:9:\"\u0000*\u0000stitle\";s:11:\"J. exp. med\";s:7:\"\u0000*\u0000date\";s:4:\"1992\";s:9:\"\u0000*\u0000volume\";s:3:\"176\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"157\";s:8:\"\u0000*\u0000epage\";s:3:\"168\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1007\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MURRAY\";s:10:\"\u0000*\u0000aufirst\";s:4:\"R. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"KURILLA, M. G\";i:1;s:12:\"BROOKS, J. M\";i:2;s:12:\"THOMAS, W. A\";i:3;s:7:\"ROWE, M\";i:4;s:8:\"KIEFF, E\";i:5;s:15:\"RICKINSON, A. B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JEMEAV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV) : implications for the immune control of EBV-positive malignancies\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:28:\"Rockefeller University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
